Naked DNA injection for liver metastases treatment in rats

被引:23
作者
Baqué, P
Pierrefite-Carle, V
Gavelli, A
Brossette, N
Benchimol, D
Bourgeon, A
Staccini, P
Saint-Paul, MC
Rossi, B
机构
[1] Hop Archet II, Serv Chirurg Abdominale & Thorac, Nice 3, France
[2] Fac Med, U INSERM 364, F-06107 Nice 2, France
关键词
D O I
10.1053/jhep.2002.32709
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The cytosine deaminase (CD) gene converts the nontoxic prodrug, 5-fluorocytosine (5-FC), into 5-fluorouracil (5-FU). We previously showed that injection of CD-bearing cancer cells followed by 5-FC treatment can act as an autologous; tumor vaccine in a syngenic liver metastasis model in rats. In the present work, we analyzed the antitumor efficiency of a direct intratumoral injection of a CD-expressing plasmid. In rats bearing microscopic or macroscopic metastases in right and left liver lobes, an injection of a CD-expressing plasmid was performed in the left lobe tumor, followed by 5-FC treatment of the animals. A significant regression of the DNA-injected tumor was observed in 5-FC-treated rats, both in microscopic (P = .007) or advanced (P < .0001) tumor models. Moreover, this treatment also induced a potent distant bystander effect on untreated controlateral liver tumors and extrahepatic metastases, resulting in an increased survival compared with control animals in both tumor models (P < .05). In conclusion, these data suggest that direct intratumoral injection of a CD-expressing plasmid, associated to 5-FC administration, can constitute a powerful and innocuous alternative treatment for unresectable liver metastases; from colon carcinoma.
引用
收藏
页码:1144 / 1152
页数:9
相关论文
共 26 条
[1]  
ACSADI G, 1991, NEW BIOL, V3, P71
[2]  
AUERBACH R, 1978, CANCER RES, V38, P1739
[3]   Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis [J].
Bentires-Alj, M ;
Hellin, AC ;
Lechanteur, C ;
Princen, F ;
Lopez, M ;
Fillet, G ;
Gielen, J ;
Merville, MP ;
Bours, V .
CANCER GENE THERAPY, 2000, 7 (01) :20-26
[4]  
Bi WL, 1997, CANCER GENE THER, V4, P246
[5]  
Budker V, 2000, J GENE MED, V2, P76, DOI 10.1002/(SICI)1521-2254(200003/04)2:2<76::AID-JGM97>3.0.CO
[6]  
2-4
[7]   F11C ANTIGEN - A MEMBRANE MARKER ABLE TO DISTINGUISH 2 REGRESSIVE AND PROGRESSIVE VARIANTS FROM A RAT COLON ADENOCARCINOMA [J].
CAIGNARD, A ;
GENNE, P ;
OLSSON, NO ;
ORIOL, R ;
MARTIN, F .
INTERNATIONAL JOURNAL OF CANCER, 1990, 46 (04) :633-639
[8]  
CONSALVO M, 1995, J IMMUNOL, V154, P5302
[9]   Suicide gene therapy for plasma cell tumors [J].
Dilber, MS ;
Abedi, MR ;
Bjorkstrand, B ;
Christensson, B ;
Gahrton, G ;
Xanthopoulos, KG ;
Smith, CIE .
BLOOD, 1996, 88 (06) :2192-2200
[10]  
FREEMAN SM, 1993, CANCER RES, V53, P5274